In the subset of patients with serum PSA levels of ≥ 20 ng/mL, older age, the presence of DRE abnormalities, higher serum PSA levels, and smaller prostate volume were predictive factors of clinically significant cancers but the pre-biopsy PLR was not. The gene discussed is KLK3; the disease is cancer.